X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6184) 6184
Publication (859) 859
Book Chapter (67) 67
Book Review (44) 44
Reference (20) 20
Magazine Article (18) 18
Book / eBook (15) 15
Conference Proceeding (9) 9
Newsletter (7) 7
Web Resource (2) 2
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4599) 4599
poliovirus - immunology (1865) 1865
animals (1645) 1645
index medicus (1590) 1590
immunology (1574) 1574
infant (1533) 1533
poliovirus (1513) 1513
poliomyelitis (1331) 1331
female (1319) 1319
vaccination (1255) 1255
male (1233) 1233
poliomyelitis - prevention & control (1210) 1210
poliomyelitis - immunology (1182) 1182
viruses (1088) 1088
child (1036) 1036
child, preschool (1031) 1031
vaccines (909) 909
immunization (897) 897
virology (856) 856
infectious diseases (851) 851
microbiology (717) 717
poliovirus vaccine, inactivated - immunology (717) 717
poliomyelitis - epidemiology (682) 682
mice (658) 658
adult (625) 625
neutralization tests (620) 620
poliovirus vaccine, oral - immunology (613) 613
poliovirus vaccine, inactivated - administration & dosage (600) 600
adolescent (597) 597
antibodies (566) 566
poliovirus - genetics (559) 559
medicine, research & experimental (533) 533
poliovirus - isolation & purification (529) 529
children (520) 520
antibodies, viral - blood (518) 518
poliovirus vaccine, oral - administration & dosage (518) 518
immunization schedule (460) 460
antibodies, viral - analysis (444) 444
research article (429) 429
infant, newborn (410) 410
molecular sequence data (398) 398
immunogenicity (389) 389
cell line (378) 378
research (375) 375
immunity (353) 353
hela cells (345) 345
poliovirus vaccine, inactivated (336) 336
poliovirus vaccine, oral (336) 336
infants (333) 333
antigens (331) 331
allergy and immunology (317) 317
infections (315) 315
vaccine (313) 313
health aspects (308) 308
pediatrics (306) 306
antibody formation (292) 292
antibodies, viral - immunology (290) 290
amino acid sequence (289) 289
poliovirus vaccine, oral - adverse effects (288) 288
poliovirus vaccine, inactivated - adverse effects (287) 287
poliovirus vaccines (283) 283
poliomyelitis - virology (281) 281
polio (280) 280
poliovirus - pathogenicity (278) 278
middle aged (276) 276
oral poliovirus vaccine (269) 269
infection (268) 268
time factors (268) 268
base sequence (267) 267
virus diseases (264) 264
virus replication (263) 263
eradication (251) 251
biotechnology & applied microbiology (249) 249
multidisciplinary sciences (247) 247
safety (244) 244
mutation (243) 243
public health (242) 242
analysis (240) 240
diphtheria-tetanus-pertussis vaccine - administration & dosage (239) 239
proteins (238) 238
epidemiology (237) 237
tetanus (235) 235
virus (234) 234
vaccines, combined - immunology (233) 233
abridged index medicus (232) 232
antigens, viral - immunology (231) 231
haemophilus vaccines - immunology (229) 229
poliovirus - classification (220) 220
diphtheria-tetanus-pertussis vaccine - immunology (219) 219
haemophilus vaccines - administration & dosage (219) 219
poliomyelitis vaccine (214) 214
vaccines, combined - administration & dosage (205) 205
poliovirus - physiology (203) 203
immunization, secondary (202) 202
diphtheria (197) 197
rna (194) 194
antibodies, bacterial - blood (193) 193
poliovirus vaccines - immunology (189) 189
inactivated poliovirus vaccine (188) 188
poliovirus vaccines - administration & dosage (186) 186
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5646) 5646
Russian (138) 138
German (122) 122
Italian (93) 93
French (78) 78
Chinese (71) 71
Japanese (60) 60
Spanish (50) 50
Polish (24) 24
Czech (19) 19
Portuguese (19) 19
Dutch (14) 14
Romanian (8) 8
Swedish (5) 5
Ukrainian (5) 5
Hungarian (4) 4
Turkish (4) 4
Finnish (3) 3
Norwegian (3) 3
Danish (2) 2
Hebrew (2) 2
Indonesian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 09/2014, Volume 41, Issue 3, pp. 478 - 492
Journal Article
PLoS One, ISSN 1932-6203, 2015, Volume 10, Issue 12, p. e0144739
BACKGROUND & AIMS: Since 2009/10, a 10- and a 13-valent pneumococcal conjugate vaccine (PCV) are available, but only the 10-valent vaccine is now being used... 
ANTIBODIES | IMMUNIZATION | MULTIPLEX IMMUNOASSAY | SAFETY | MULTIDISCIPLINARY SCIENCES | DISEASE | BORDETELLA-PERTUSSIS | NETHERLANDS | PHID-CV | SEROTYPE 19A | CHILDREN | Streptococcus pneumoniae - classification | Immunoglobulin G - blood | Haemophilus influenzae type b - drug effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Child, Preschool | Haemophilus Infections - prevention & control | Infant | Haemophilus Vaccines - administration & dosage | Haemophilus influenzae type b - immunology | Pneumococcal Vaccines - administration & dosage | Tetanus - microbiology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Whooping Cough - microbiology | Poliovirus Vaccine, Inactivated - immunology | Streptococcus pneumoniae - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Netherlands | Pneumococcal Infections - immunology | Immunization, Secondary | Vaccination - methods | Time Factors | Immunoglobulin G - immunology | Tetanus - immunology | Whooping Cough - prevention & control | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Diphtheria - prevention & control | Immunization Schedule | Pneumococcal Infections - microbiology | Diphtheria - microbiology | Antibodies, Bacterial - blood | Serotyping | Antibody Formation - immunology | Streptococcus pneumoniae - drug effects | Diphtheria - immunology | Hepatitis B Vaccines - administration & dosage | Tetanus - prevention & control | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Haemophilus Infections - microbiology | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Antibodies, Bacterial - immunology | Hepatitis B Vaccines - immunology | Haemophilus Infections - immunology | Whooping Cough - immunology | Physiological aspects | Genetic aspects | Immune response | Research | Pneumococcal vaccine | Pediatrics | Immunoglobulin G | Childrens health | Infants | Vaccines | Streptococcus infections | Proteins | Pertussis | Children | Age | Public health | Antigens | Immunization | Immunoglobulins | Mortality | Diphtheria | Disease control | Opsonophagocytosis | Whooping cough | Infectious diseases | Immunogenicity | Correlation analysis | Serotypes | Avidity | Tetanus | Carrier density
Journal Article
Journal Article
European Journal of Immunology, ISSN 0014-2980, 06/2017, Volume 47, Issue 6, pp. 1040 - 1050
Human cytomegalovirus (HCMV) infection drives the phenotypic and functional differentiation of NK cells, thereby influencing the responses of these cells after... 
DTPiP vaccine | NK cells | NKG2C | Influenza vaccine | Vaccination | NATURAL-KILLER-CELLS | ACTIVATION | RECEPTOR | IL-2 | IMMUNOLOGY | RESPONSES | HUMAN CYTOMEGALOVIRUS-INFECTION | DISEASE | DIFFERENTIATION | EXPRESSION | T-CELLS | Africa - epidemiology | Cytomegalovirus Infections - ethnology | Influenza Vaccines - administration & dosage | Interleukin-18 - immunology | Vaccine Potency | Humans | Middle Aged | Child, Preschool | Male | Cytomegalovirus Infections - immunology | Diphtheria Toxoid - immunology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Young Adult | Immunization, Secondary | Interleukins - immunology | Lysosomal-Associated Membrane Protein 1 - immunology | Cytomegalovirus Infections - virology | Killer Cells, Natural - immunology | Adult | Female | Child | Interleukin-12 - pharmacology | Interleukin-2 Receptor alpha Subunit - immunology | Poliovirus Vaccines - administration & dosage | Tetanus Toxoid - administration & dosage | Cytomegalovirus - immunology | Influenza Vaccines - pharmacology | Diphtheria Toxoid - administration & dosage | Influenza Vaccines - immunology | Interferon-gamma - immunology | Adolescent | Interleukin-12 - immunology | Aged | Interleukin-18 - pharmacology | Killer Cells, Natural - drug effects | Poliovirus Vaccines - immunology | Tetanus Toxoid - immunology | Interferon-gamma - biosynthesis | Antigens | Immunization | Populations | Cytokines | Differentiation (biology) | Interleukin 12 | Stimulation | Exposure | Infections | Vaccines | Diphtheria | Interleukin 18 | Exploitation | Pertussis | NKG2 antigen | Cell activation | Influenza | CD25 antigen | Tetanus | Natural killer cells | In vitro methods and tests | Clinical | Immunity to infection
Journal Article
Pediatrics, ISSN 0031-4005, 08/2014, Volume 134, Issue 2, pp. e362 - e372
OBJECTIVE: Oral vaccine efficacy is low in less-developed countries, perhaps due to intestinal dysbiosis. This study determined if stool microbiota composition... 
Proteobacteria | Bifidobacterium | Antibody | Polio | Vaccine | Intestinal | Hepatitis | Bangladesh | Microbiota | Tuberculosis | Actinobacteria | T lymphocyte | Tetanus | microbiota | SYSTEM | antibody | PROBIOTIC BACTERIA | INTESTINAL MICROBIOTA | tuberculosis | COLONIZATION | GUT MICROBIOTA | hepatitis | MATURATION | polio | intestinal | vaccine | tetanus | EVOLUTION | IMMUNE-RESPONSES | DISEASE | PEDIATRICS | DIVERSITY | Poliovirus Vaccine, Oral - immunology | Humans | Infant | Male | Vaccines - therapeutic use | Bifidobacterium - isolation & purification | Dysbiosis - immunology | Feces - microbiology | Enterobacteriaceae - immunology | Female | Actinobacteria - isolation & purification | Nutritional Status | Pseudomonas - immunology | RNA, Ribosomal, 16S | DNA, Bacterial - isolation & purification | Microbiota - immunology | Tetanus Toxoid - therapeutic use | Vaccines - immunology | Sequence Analysis, DNA | Hepatitis B Vaccines - therapeutic use | BCG Vaccine - immunology | T-Lymphocytes - immunology | Thymus Gland - immunology | Hepatitis B Vaccines - immunology | Microbiological Techniques | BCG Vaccine - therapeutic use | Tetanus Toxoid - immunology | Infants | Research | Vaccines | Microbiota (Symbiotic organisms) | Health aspects | Polymerase chain reaction | Babies | Bacteria | Immunoglobulins | Lymphocytes
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 7/2013, Volume 208, Issue 2, pp. 275 - 283
Background. Phase II and III clinical studies were conducted to evaluate immunogenicity and safety of a novel DTaP-IPV vaccine consisting of Sabin inactivated... 
Control groups | Immunization | Immune response | Oral poliovirus vaccine | Diptheria pertussis tetanus vaccine | Neutralizing antibodies | Vaccination | Secondary immunization | Poliovirus | VIRUSES | Whooping cough | clinical study | Sabin strain | combination vaccine | IPV | DTaP | INFECTIOUS DISEASES | EFFICACY | SAFETY | ENHANCED-POTENCY | MICROBIOLOGY | IMMUNOLOGY | TRIAL | IMMUNOGENICITY | POLIOMYELITIS | JAPAN | TECHNOLOGY-TRANSFER | Poliovirus Vaccine, Oral - immunology | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Male | Poliovirus Vaccine, Oral - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Tetanus - immunology | Whooping Cough - prevention & control | Diphtheria - prevention & control | Female | Immunization Schedule | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Antibody Formation - immunology | Diphtheria - immunology | Double-Blind Method | Tetanus - prevention & control | Immunization, Secondary - methods | Poliomyelitis - prevention & control | Poliomyelitis - immunology | Poliovirus - immunology | Antibodies, Bacterial - immunology | Antibodies, Viral - immunology | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Whooping Cough - immunology | Dosage and administration | Safety and security measures | Research | Poliomyelitis vaccine | DPT vaccine
Journal Article
Journal Article